About: Motexafin lutetium

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Motexafin lutetium is a texaphyrin, marketed as Antrin by Pharmacyclics Inc. It is a photosensitiser for use in photodynamic therapy to treat skin conditions and superficial cancers. It has also been tested for use in (photodynamic treatment of diseased arteries). It is photoactivated by 732 nm light which allows greater depth of penetration.

Property	Value
dbo:abstract	Motexafin lutetium is a texaphyrin, marketed as Antrin by Pharmacyclics Inc. It is a photosensitiser for use in photodynamic therapy to treat skin conditions and superficial cancers. It has also been tested for use in (photodynamic treatment of diseased arteries). It is photoactivated by 732 nm light which allows greater depth of penetration. (en)
dbo:alternativeName	Antrin; Lu texaphyrin; Lu-Tex; Lutetium texaphyrin; Lutrin; Optrin; PCI 0123 (en)
dbo:thumbnail	wiki-commons:Special:FilePath/Motexafin_lutetium.svg?width=300
dbo:wikiPageID	25403891 (xsd:integer)
dbo:wikiPageLength	2993 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1093497878 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Prostate_cancer dbc:Tetrapyrroles dbr:Photodynamic_therapy dbc:Lutetium_complexes dbr:Texaphyrin dbr:Photoangioplasty
dbp:imagefile	Motexafin lutetium.svg (en)
dbp:imagesize	200 (xsd:integer)
dbp:othernames	Antrin; Lu texaphyrin; Lu-Tex; Lutetium texaphyrin; Lutrin; Optrin; PCI 0123 (en)
dbp:verifiedrevid	455343846 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Chembox dbt:Chembox_Hazards dbt:Chembox_Identifiers dbt:Chembox_Properties dbt:Dermatologic-drug-stub dbt:Reflist dbt:Cascite dbt:Fdacite dbt:Lutetium_compounds
dcterms:subject	dbc:Tetrapyrroles dbc:Lutetium_complexes
gold:hypernym	dbr:Texaphyrin
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q11173 yago:WikicatLutetiumCompounds yago:WikicatMolecularFormulas yago:Abstraction100002137 yago:Cognition100023271 yago:Communication100033020 yago:Compound105870180 yago:Concept105835747 yago:Content105809192 yago:Formula106816935 yago:Idea105833840 yago:Message106598915 yago:MolecularFormula106817173 yago:PsychologicalFeature100023100 dbo:ChemicalCompound yago:Statement106722453 yago:Whole105869584 umbel-rc:ChemicalSubstanceType
rdfs:comment	Motexafin lutetium is a texaphyrin, marketed as Antrin by Pharmacyclics Inc. It is a photosensitiser for use in photodynamic therapy to treat skin conditions and superficial cancers. It has also been tested for use in (photodynamic treatment of diseased arteries). It is photoactivated by 732 nm light which allows greater depth of penetration. (en)
rdfs:label	Motexafin lutetium (en)
owl:sameAs	freebase:Motexafin lutetium yago-res:Motexafin lutetium wikidata:Motexafin lutetium dbpedia-sh:Motexafin lutetium dbpedia-sr:Motexafin lutetium https://global.dbpedia.org/id/4sBYU
prov:wasDerivedFrom	wikipedia-en:Motexafin_lutetium?oldid=1093497878&ns=0
foaf:depiction	wiki-commons:Special:FilePath/Motexafin_lutetium.svg
foaf:isPrimaryTopicOf	wikipedia-en:Motexafin_lutetium
is dbo:wikiPageRedirects of	dbr:C52H72LuN5O14 dbr:Antrin dbr:Optrin dbr:Lu-Tex dbr:Lu_texaphyrin dbr:Lutetium_texaphyrin dbr:Lutrin
is dbo:wikiPageWikiLink of	dbr:List_of_compounds_with_carbon_numbers_50+ dbr:C52H72LuN5O14 dbr:Photodynamic_therapy dbr:Antrin dbr:Texaphyrin dbr:List_of_drugs:_Mo dbr:Optrin dbr:Lu-Tex dbr:Lu_texaphyrin dbr:Lutetium_texaphyrin dbr:Lutrin
is foaf:primaryTopic of	wikipedia-en:Motexafin_lutetium